gms | German Medical Science

23rd Annual Meeting of the German Retina Society

German Retina Society

24.09. - 25.09.2010, Freiburg

Article

Send article

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study – RABAMES-Study: Characteristics of the laser treatment groups

Meeting Abstract

Search Medline for

  • Amelie Pielen - University Eye Clinic Freiburg i. Br.
  • B. Junker - University Eye Clinic Freiburg i. Br.
  • L.L. Hansen - University Eye Clinic Freiburg i. Br.
  • N. Feltgen - University Eye Clinic Göttingen
  • A. Mirshahi - University Eye Clinic Mainz
  • L.-O. Hattenbach - Hospital of the City of Ludwigshafen, Eye Clinic
  • Rabames-Studiengruppe

German Retina Society. 23rd Annual Conference of the German Retina Society. Freiburg i. Br., 24.-25.09.2010. Düsseldorf: German Medical Science GMS Publishing House; 2010. Doc10rg77

doi: 10.3205/10rg77, urn:nbn:de:0183-10rg772

This is the English version of the article.
The German version can be found at: http://www.egms.de/de/meetings/rg2010/10rg77.shtml

Published: September 21, 2010

© 2010 Pielen et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

Outline

Text

Purpose: 30 patients with significant macular edema secondary to branch retinal vein occlusion were included in the Rabames-study, if symptoms were present for more than 12 months and less than 18 months. Patients were randomised 1:1:1 to the following treatment groups: (1) 3 intravitreal injections of Ranibizumab monthly, (2) grid lasercoagulation at month 1 and at month 3 optionally, (3) combination of 3 intravitreal injections of Ranibizumab monthly and grid lasercoagulation at month 1 and at month 3 optionally. Follow-up was 6 months.

Methods: Analysis of the characteristics of the 2 laser treatment groups. Specific character of laser treatment. Proportion of patients receiving scatter or grid laser treatment. Analysis of patients with one laser treatment versus multiple laser treatment. Comparison of laser treatment performed in the Rabames-study with treatment pattern of the Branch Vein Occlusion (BVO)-study.

Conclusion: Characteristics of the two laser treatment groups of the Rabames-study shall be presented and analysed as a quality control.

Results: Complete data analysis was not possible before abstract deadline. Nevertheless data will be completely collected up to the time of the meeting.

We would be glad to present our data for the first time at the Retinologische Gesellschaft 2010.